James T. Prokopanko
Analyst · Joel Jackson, BMO Capital Markets
Good morning to you all. Thank you for joining our fourth quarter earnings meeting. A year ago, on our fourth quarter 2013 earnings call, I said the following: We're starting to see some rays of sunlight at the end of this tunnel, and Mosaic is well positioned for the daylight to come. Well, our predictions don't always come true, but in this case, it's very gratifying to be proven right. The sunlight was real and Mosaic was, and is, in excellent position to benefit in better parts of the business cycle. Given that we updated our earnings expectations in mid-January, we realized our results don't come as a surprise. So today, we will focus on the drivers behind our strong finish to the year and we'll discuss our outlook for 2015. Our key messages for today are: First, our earnings are beginning to reflect the leverage we've built into the business through our many strategic moves. I want to emphasize that we outperformed expectations without significant appreciation in prices for our products or in the prices of grains and oilseeds. Second, robust demand for our products and good execution were the primary drivers of our earnings, and we expect global demand to remain strong in 2015. And third, we are successfully executing our strategic initiatives and many of them are now fully operationalized. For the quarter, Mosaic earned $361 million or $0.97 per share, including a positive impact of $0.10 per share of notable items, an increase of roughly threefold from a year ago. Our revenues for the quarter were $2.4 billion, up 9% over the fourth quarter of 2013. Both of Mosaic's business segments outperformed our expectations. In Phosphates, our volumes exceeded the top of our initial guidance range by 450,000 tonnes as customers sought to position inventory in anticipation of a strong spring application season. The Phosphates segment generated $286 million in gross margin and improved its gross margin rate to 18.2% during the quarter. The Potash segment exceeded our gross margin guidance by several percentage points as cost per tonne dropped and we operated at very high operating rates, mostly because of a highly successful Canpotex proving run at Colonsay. We also continued to generate strong operating cash flow of $382 million during the quarter, bringing our full year cash flow from operations to $2.3 billion, an almost $300 million improvement over 2013. We are putting our cash to use by continuing to invest in the business, both organically and strategically, and repurchasing our shares. And we ended the quarter with $2.4 billion of cash and cash equivalents. For the full year of 2014, we delivered good results despite the choppy market conditions throughout the year. Mosaic earned $1 billion on revenues of $9.1 billion, both essentially flat when compared with 2013, but with significantly more positive trends exiting the year. We have built a business model that is both resilient to challenging market conditions and positioned to accelerate quickly as conditions improve. Our results for the quarter and the year corroborate both of these concepts. Market conditions stabilized in the fourth quarter, but grain and oilseed prices remained relatively low. Demand for our products, on the other hand, was extremely strong. Our fourth quarter is typically a seasonally slow period for us, but our customers came to the market in force. We met the demand with excellent operational performance. Our potash mines ran at 91% of capacity, higher than expected because of the strong demand and the Colonsay proving run I mentioned earlier. Going into the quarter, producer inventories were very low and despite running all out, we shipped rather than stored the vast majority of the potash tonnes we produced. The phosphate story has also been good. Global demand for phosphates has been strong for some time, and the trend continued in the fourth quarter. In November, we announced and executed a phosphate production curtailment in response to high raw material costs. Ammonia prices softened and customers stepped in to purchase our products, and as a result, we were able to exit the fourth quarter without building high-cost inventory for the spring season. This is a good illustration of our market leadership in phosphates. I'd now like to highlight some of the other progress we made during the quarter and the year. As I mentioned, we completed a successful Canpotex proving run at Colonsay, significantly exceeding targeted production. As a result, our peaking capacity increased by 700,000 tonnes, and our Canpotex entitlement is now 40.6% effective January 2015. In total, our proving runs for Esterhazy and Colonsay added 1.7 million tonnes compared to the expected increase of 1.3 million tonnes, almost 30% higher. These exceptional results were delivered on budget and on time. The CF acquisition and integration are, for all intents and purposes, complete, and we are generating better-than-expected financial and operational synergies from the additional facilities. The ADM distribution acquisition in Brazil and Paraguay closed near the end of the year, and integration work is proceeding well. We are now a major player in South America with the capacity to distribute 6 million tonnes of product. We continue to be on track for the first phase of our Esterhazy K3 project, which is expected to begin delivering tonnes in 2017. The board has approved the modification of the original scope to accelerate the second phase of K3 development. The accelerated construction plan will move up the time frame when we could execute the option to replace underground mining operations at K1 and K2 and, thus, entirely eliminate brine management costs. We'll discuss the Esterhazy expansion and the options it gives us in more detail at our Analyst Day next month. We completed the divestitures of our Southern Cone operations, sold our Hersey mine and discontinued higher-cost MOP production at our Carlsbad mine. Those facilities were not meeting our return expectations and those moves are behind us. We're significantly ahead of plan in our expense savings initiatives with identified savings of $500 million to be realized over a 5-year period. Rich Mack, our CFO, will cover the capital and balance sheet work we accomplished this year in more detail, but I would like to note that we reached our debt leverage target while returning more than $3.1 billion to shareholders. And last but not least, the Ma'aden project continues to rise from the desert, and we've included a couple of recent photos of the facility in our slide presentation today. 2014 was a busy year for Mosaic, but we are not resting. As we move into this year, we're proceeding with the evaluation of a de-bottlenecking project at our Faustina, Louisiana, ammonia plant. Our MicroEssentials conversion at New Wales is well underway, and we are also building a sulfur smelter at our New Wales, Florida, plant in close proximity to other chemical plants so that we will be more self-sufficient in phosphate, raw material sourcing. We believe the investments we're making will allow us to maintain our advantage as a low-cost producer. We accomplished all this work and all the normal course of business work while once again improving our safety performance. We set records in our key safety measures for the third consecutive year, which is a real source of pride for the Mosaic team. This long list of accomplishments distinguishes Mosaic by our ability to execute on projects that will benefit our shareholders. Mosaic is indeed a much more powerful franchise at the end of 2014 than just a year ago. We're thrilled with our progress and we're excited about the future. Before I talk about our outlook for this year, I'd like to ask Rich Mack to provide more detail on the quarter and our capital. Rich?